Podocyte p53 Limits the Severity of Experimental Alport Syndrome

Journal of the American Society of Nephrology

Volumn 27, Issue 1, 2016, Pages 144-157

  Fukuda, Ryosuke ^a   Suico, Mary Ann ^a   Kai, Yukari ^a   Omachi, Kohei ^a   Motomura, Keishi ^a   Koga, Tomoaki ^b   Komohara, Yoshihiro ^a   Koyama, Kosuke ^a   Yokota, Tsubasa ^a   Taura, Manabu ^a   Shuto, Tsuyoshi ^a   Kai, Hirofumi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ABP1 PROTEIN; CDC2A PROTEIN; CDKN3 PROTEIN; CKAP2L PROTEIN; KIF11 PROTEIN; KIF20A PROTEIN; KIF22 PROTEIN; LYSOZYME; MESSENGER RNA; NEPHRIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; NITROGEN; NUTLIN 3; PBK PROTEIN; PIFITHRIN ALPHA; PODOCIN; PROTEIN; PROTEIN P21; PROTEIN P53; RACGAP1 PROTEIN; RSPO1 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UREA;

ALPORT SYNDROME; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL EXPANSION; CELL MIGRATION; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; DOWN REGULATION; GENE EXPRESSION; GLOMERULUS; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CORTEX; KIDNEY FIBROSIS; KIDNEY FUNCTION; MALE; MICROARRAY ANALYSIS; MOUSE; NEPHRITIS; NONHUMAN; PHENOTYPE; PODOCYTE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEINURIA; SURVIVAL; SURVIVAL RATE; TRANSMISSION ELECTRON MICROSCOPY; TUNEL ASSAY; UPREGULATION; UREA NITROGEN BLOOD LEVEL; ANIMAL; NEPHRITIS, HEREDITARY; PHYSIOLOGY; SEVERITY OF ILLNESS INDEX;

ANIMALS; MALE; MICE; NEPHRITIS, HEREDITARY; PODOCYTES; SEVERITY OF ILLNESS INDEX; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84954426592     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2014111109     Document Type: Article

References (52)

1. Lemmink HH, Schröder CH, Monnens LA, Smeets HJ: The clinical spectrum of type IV collagen mutations. Hum Mutat 9: 477-499, 1997
2. Martin P, Heiskari N, Zhou J, Leinonen A, Tumelius T, Hertz JM, Barker D, Gregory M, Atkin C, Styrkarsdottir U, Neumann H, Springate J, Shows T, Pettersson E, Tryggvason K: High mutation detection rate in the COL4A5 collagen gene in suspected Alport syndrome using PCR and direct DNA sequencing. J Am Soc Nephrol 9: 2291-2301, 1998
3. Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG: Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med 348: 2543-2556, 2003
4. Cosgrove D: Glomerular pathology in Alport syndrome: A molecular perspective. Pediatr Nephrol 27: 885-890, 2012
5. Moeller MJ, Soofi A, Hartmann I, Le Hir M,Wiggins R, Kriz W, Holzman LB: Podocytes populate cellular crescents in a murine model of inflammatory glomerulonephritis. J Am Soc Nephrol 15: 61-67, 2004
6. Ryu M, Migliorini A, Miosge N, Gross O, Shankland S, Brinkkoetter PT, Hagmann H, Romagnani P, Liapis H, Anders HJ: Plasma leakage through glomerular basement membrane ruptures triggers the proliferation of parietal epithelial cells and crescent formation in noninflammatory glomerular injury. J Pathol 228: 482-494, 2012
7. Muller PA, Vousden KH, Norman JC: P53 and its mutants in tumor cell migration and invasion. J Cell Biol 192: 209-218, 2011
8. Eid AA, Ford BM, Block K, Kasinath BS, Gorin Y, Ghosh-Choudhury G, Barnes JL, Abboud HE: AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes. J Biol Chem285: 37503-37512, 2010
9. Wada T, Pippin JW, Marshall CB, Griffin SV, Shankland SJ: Dexamethasone prevents podocyte apoptosis induced by puromycin aminonucleoside: Role of p53 and Bcl-2-related family proteins. J Am Soc Nephrol 16: 2615-2625, 2005
10. Zhang D, Liu Y, Wei Q, Huo Y, Liu K, Liu F, Dong Z: Tubular p53 regulates multiple genes to mediate AKI. J Am Soc Nephrol 25: 2278-2289, 2014
11. Srivastava T, Garola RE, Whiting JM, Alon US: Cell-cycle regulatory proteins in podocyte cell in idiopathic nephrotic syndrome of childhood. Kidney Int 63: 1374-1381, 2003
12. Liapis H, Romagnani P, Anders HJ: New insights into the pathology of podocyte loss:mitotic catastrophe. Am J Pathol 183: 1364-1374, 2013
13. Rheault MN, Kren SM, Thielen BK, Mesa HA, Crosson JT, Thomas W, Sado Y, Kashtan CE, Segal Y: Mouse model of X-linked Alport syndrome. J Am Soc Nephrol 15: 1466-1474, 2004
14. Silverstein DM: Inflammation in chronic kidney disease: Role in the progression of renal and cardiovascular disease. Pediatr Nephrol 24: 1445-1452, 2009
15. Liu Y: Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol 7: 684-696, 2011
16. Moldavsky M: Lysozyme immunostaining in renal tubular dysgenesis. Pediatr Dev Pathol 3: 200-201, 2000
17. Huttenlocher A, Sandborg RR, Horwitz AF: Adhesion in cell migration. Curr Opin Cell Biol 7: 697-706, 1995
18. Kreidberg JA: Podocyte differentiation and glomerulogenesis. J Am Soc Nephrol 14: 806-814, 2003
19. Chao CC: Mechanisms of p53 degradation. Clin Chim Acta 438: 139-147, 2015
20. Pontén F, Jirström K, Uhlen M: The Human Protein Atlas-a tool for pathology. J Pathol 216: 387-393, 2008
21. Nishida T, Matsushima T, Tsujimoto M, Takahashi T, Kawasaki Y, Nakayama S, Omori T, Yamamura M, Cho H, Hirota S, Ueshima S, Ishihara H: Cyclin-dependent kinase activity correlates with the prognosis of patients who have gastrointestinal stromal tumors [published online ahead of print February 24, 2015]. Ann SurgOncol doi:10.1245/sl0434-015-4438-y
22. Li T, Xue H, Guo Y, Guo K: CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer. Oncol Rep 31: 1825-1831, 2014
23. Lei B, Qi W, Zhao Y, Li Y, Liu S, Xu X, Zhi C, Wan L, Shen H: PBK/TOPK expression correlates with mutant p53 and affects patients' prognosis and cell proliferation and viability in lung adenocarcinoma. HumPathol 46: 217-224, 2015
24. Choi EJ, Yun JA, Jeon EK, Won HS, Ko YH, Kim SY: Prognostic significance of RSPO1, WNT1, P16, WT1, and SDC1 expressions in invasive ductal carcinoma of the breast. World J Surg Oncol 11: 314, 2013
25. Taniuchi K, Furihata M, Saibara T: KIF20A-mediated RNA granule transport system promotes the invasiveness of pancreatic cancer cells. Neoplasia 16: 1082-1093, 2014
26. Yu Y, Wang XY, Sun L, Wang YL, Wan YF, Li XQ, Feng YM: Inhibition of KIF22 suppresses cancer cell proliferation by delaying mitotic exit through upregulating CDC25C expression. Carcinogenesis 35: 1416-1425, 2014
27. Valensin S, Ghiron C, Lamanna C, Kremer A, Rossi M, Ferruzzi P, Nievo M, Bakker A: KIF11 inhibition for glioblastoma treatment: Reason to hope or a struggle with the brain? BMC Cancer 9: 196, 2009
28. Imaoka H, Toiyama Y, Saigusa S, KawamuraM, Kawamoto A, Okugawa Y,Hiro J, Tanaka K, Inoue Y,Mohri Y, KusunokiM: RacGAP1 expression, increasing tumor malignant potential, as a predictive biomarker for lymph node metastasis and poor prognosis in colorectal cancer. Carcinogenesis 36: 346-354, 2015
29. Donehower LA,HarveyM, Slagle BL,McArthurMJ,Montgomery CA Jr, Butel JS, Bradley A:Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215-221, 1992
30. Vousden KH, Lu X: Live or let die: The cell's response to p53. Nat Rev Cancer 2: 594-604, 2002
31. Hodge DR, Peng B, Cherry JC, Hurt EM, Fox SD, Kelley JA, Munroe DJ, Farrar WL: Interleukin 6 supports the maintenance of p53 tumor suppressor gene promoter methylation. Cancer Res 65: 4673-4682, 2005
32. Ghosh A, Chen TC, Kapila YL: Anoikis triggers Mdm2-dependent p53 degradation. Mol Cell Biochem 343: 201-209, 2010
33. Hilliard SA, Yao X, El-Dahr SS: Mdm2 is required formaintenance of the nephrogenic niche. Dev Biol 387: 1-14, 2014
34. Aboudehen K, Hilliard S, Saifudeen Z, El-Dahr SS: Mechanisms of p53 activation and physiological relevance in the developing kidney. Am J Physiol Renal Physiol 302: F928-F940, 2012
35. Gudkov AV, Gurova KV, Komarova EA: Inflammation and p53: A Tale of Two Stresses. Genes Cancer 2: 503-516, 2011
36. Delimont D, Dufek BM, Meehan DT, Zallocchi M, Gratton MA, Phillips G, Cosgrove D: Laminin a2-mediated focal adhesion kinase activation triggers Alport glomerular pathogenesis. PLoS ONE 9: E99083, 2014
37. Golubovskaya VM, Cance WG: FAK and p53 protein interactions. Anticancer Agents Med Chem 11: 617-619, 2011
38. Meyer E, Vollmer JY, Bovey R, Stamenkovic I: Matrix metalloproteinases 9 and 10 inhibit protein kinase C-potentiated, p53-mediated apoptosis. Cancer Res 65: 4261-4272, 2005
39. Tanaka M, Asada M, Higashi AY, Nakamura J, Oguchi A, Tomita M, Yamada S, Asada N, Takase M, Okuda T, Kawachi H, Economides AN, Robertson E, Takahashi S, Sakurai T, Goldschmeding R, Muso E, Fukatsu A, Kita T, Yanagita M: Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome. J Clin Invest 120: 768-777, 2010
40. Linker RA,Mäurer M,Gaupp S,Martini R,HoltmannB, Giess R, Rieckmann P, Lassmann H, Toyka KV, Sendtner M,Gold R:CNTF is amajor protective factor in demyelinating CNS disease: A neurotrophic cytokine as modulator in neuroinflammation. Nat Med 8: 620-624, 2002
41. Su B, ZhaoW, Shi B, Zhang Z, Yu X, Xie F,Guo Z, Zhang X, Liu J, ShenQ, Wang J, Li X, Zhang Z, Zhou L: Let-7d suppresses growth, metastasis, and tumor macrophage infiltration in renal cell carcinoma by targeting COL3A1 and CCL7. Mol Cancer 13: 206, 2014
42. Chassot AA, Gregoire EP, Lavery R, TaketoMM, de RooijDG,Adams IR, Chaboissier MC: RSPO1/b-catenin signaling pathway regulates oogonia differentiation and entry into meiosis in the mouse fetal ovary. PLoS ONE 6: E25641, 2011
43. Sutton TA, Hato T, Mai E, Yoshimoto M, Kuehl S, AndersonM,Mang H, Plotkin Z, Chan RJ, Dagher PC: P53 is renoprotective after ischemic kidney injury by reducing inflammation. J Am Soc Nephrol 24: 113-124, 2013
44. Dagher PC, Mai EM, Hato T, Lee SY, Anderson MD, Karozos SC, Mang HE, Knipe NL, Plotkin Z, Sutton TA: The p53 inhibitor pifithrin-a can stimulate fibrosis in a rat model of ischemic acute kidney injury. Am J Physiol Renal Physiol 302: F284-F291, 2012
45. Molitoris BA,Dagher PC, Sandoval RM,Campos SB, AshushH, Fridman E, Brafman A, Faerman A, Atkinson SJ, Thompson JD, Kalinski H, Skaliter R, Erlich S, Feinstein E: SiRNA targeted to p53 attenuates ischemic and cisplatin-induced acute kidney injury.JAmSocNephrol 20: 1754-1764, 2009
46. Fujino T, Muhib S, Sato N, Hasebe N: Silencing of p53 RNA through transarterial delivery ameliorates renal tubular injury and downregulates GSK-3b expression after ischemia-reperfusion injury. Am J Physiol Renal Physiol 305: F1617-F1627, 2013
47. Mundel P, Reiser J, Zúñiga Mejía Borja A, Pavenstädt H, Davidson GR, KrizW, Zeller R: Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 236: 248-258, 1997
48. Moeller MJ, Sanden SK, Soofi A, Wiggins RC, Holzman LB: Podocytespecific expression of Cre recombinase in transgenicmice. Genesis 35: 39-42, 2003
49. Tsukada T, Tomooka Y, Takai S, Ueda Y, Nishikawa S, Yagi T, Tokunaga T, Takeda N, Suda Y, Abe S, et al: Enhanced proliferative potential in culture of cells fromp53-deficientmice. Oncogene 8: 3313-3322, 1993
50. TakemotoM, Asker N, Gerhardt H, Lundkvist A, Johansson BR, Saito Y, Betsholtz C: A new method for large scale isolation of kidney glomeruli from mice. Am J Pathol 161: 799-805, 2002
51. Koga T, Kai Y, Fukuda R, Morino-Koga S, Suico MA, Koyama K, Sato T, Shuto T, Kai H: Mild electrical stimulation and heat shock ameliorates progressive proteinuria and renal inflammation in mouse model of Alport syndrome. PLoS ONE 7: E43852, 2012
52. Bollée G, Flamant M, Schordan S, Fligny C, Rumpel E, Milon M, Schordan E, Sabaa N, Vandermeersch S, Galaup A, Rodenas A, Casal I, Sunnarborg SW, Salant DJ, Kopp JB, Threadgill DW, Quaggin SE, Dussaule JC, Germain S, Mesnard L, Endlich K, Boucheix C, Belenfant X, Callard P, Endlich N, Tharaux PL: Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis. Nat Med 17: 1242-1250, 2011